Top Markets
Coin of the day
GeneThera, Inc. GeneThera, Inc.

GeneThera, Inc.

GTHR
Peringkat dalam Saham #42192
GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced... GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced diagnostic tools and therapeutic solutions for diseases that can transfer from animals to humans (zoonotic diseases). The company's portfolio includes treatments for a variety of these conditions, such as COVID-19, and illnesses like paratuberculosis (Johne's disease), currently in its Stage III clinical phase, as well as mad cow and chronic wasting diseases, and common bacterial infections like E.coli and salmonella. Furthermore, GeneThera is developing a vaccine specifically targeting Mycobacterium avium subspecies paratuberculosis bacteria. Utilizing its innovative Molecular Robotic/AI Platform and a strategic therapeutic framework, the company strives to inhibit the spread of animal-borne diseases and improve control over zoonotic infectious agents. GeneThera, Inc. operates out of Westminster, Colorado.
Harga Saham
$0.0001
Terakhir disinkronkan: 2025-03-10
Kapitalisasi Pasar
$3.53K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan GeneThera, Inc. (GTHR)

Kategori

Rasio P/B untuk GeneThera, Inc. (GTHR)
Rasio P/B per 2026 TTM: 0
Menurut laporan keuangan dan harga saham terbaru dari GeneThera, Inc., rasio P/B saat ini (TTM) adalah 0. Pada akhir 2026, rasio P/B perusahaan adalah 0.
Riwayat rasio P/B untuk GeneThera, Inc. dari 2026 hingga 2026
Rasio P/B pada akhir setiap tahun
Tahun Rasio P/B Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Rasio P/B untuk perusahaan sejenis atau pesaing
Perusahaan Rasio P/B Perbedaan Rasio P/B Negara
6.2613 -
US
6.3483 -
NL
- -
CH
3.634 -
BE
- -
KR